[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@zohmbastic Avatar @zohmbastic zohm

No specific company named "zohm" appears in the provided tweets. However, various companies are trending with updates on earnings, analyst upgrades and downgrades, and new partnerships. Some companies like $MARa, $FIVE, and $RLX reported strong quarterly earnings.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXX% finance XXXX% cryptocurrencies #6080 technology brands XXXX% countries XXXX% exchanges XXXX% fashion brands XXXX%

Social topic influence target #686, $sg #6, price target #10, $wrby #7, $barcl #90, strong 1.89%, $dbrg 1.89%, $adma #7, morgan stanley #54, $tern #17

Top accounts mentioned or mentioned by @sandman7591 @pnani456 @jefftheomega1 @maximusholla @traderjon01 @hannibalspeaks @doepkemichel @quantumup1 @sm95190513 @boxlongs @stocktalkweekly @marketprophit @joserestonva @margaret252384 @almightyzeeza @josericaurtej @tagthatstock @byebyegoodguy @fabiomclean @fd_coop_ny

Top assets mentioned Sweetgreen, Inc. (SG) Warby Parker Inc. (WRBY) DigitalBridge Group, Inc. (DBRG) ADMA Biologics, Inc. (ADMA) Morgan Stanley (MS) Terns Pharmaceuticals, Inc. Common Stock (TERN) Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Guardant Health, Inc. Common Stock (GH) Planet Labs PBC (PL) Waystar Holding Corp. Common Stock (WAY) Etoro (ETOR) NVIDIA Corp. (NVDA) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) UiPath, Inc. (PATH) Travere Therapeutics, Inc. Common Stock (TVTX) OneStream, Inc. Class A Common Stock (OS) Rocket Companies, Inc. (RKT) Exact Sciences Corp (EXAS) Helium IOT (IOT) Synopsys, Inc. (SNPS) Banco BBVA Argentina S.A. (BBAR) Cidara Therapeutics, Inc. (CDTX) One Cash (ONC) A3S Protocol (AA) Kohl's Corporation (KSS) Goldman Sachs (GS) Victoria's Secret & Co. (VSCO) Smooth Love Potion (SLP) Apogee Therapeutics, Inc. Common Stock (APGE) Gemini Space Station, Inc. Class A Common Stock (GEMI) Applied Blockchain, Inc. Common Stock (APLD) EQIFi (EQX) Viavi Solutions Inc. Common Stock (VIAV) 69Coin (69)

Top Social Posts

Top posts by engagements in the last XX hours

"$TEVA Barclays initiated coverage of Teva with an Overweight rating and $XX price target. The firm rolled out coverage on the specialty pharmaceuticals industry with a neutral view saying investor sentiment is improving as companies shift focus to innovation margin expansion and de-leveraging. The group's pricing headwinds are easing while debt leverage is coming down the analyst tells investors in a research note. Barclays sees "plenty of opportunity" as the sector "remains in a transition phase.""
X Link 2025-12-08T21:29Z 9426 followers, 2652 engagements

"$U Needham and Wedbush PT XX almost there"
X Link 2025-12-09T19:37Z 9426 followers, 2286 engagements

"$WRBY trimming a few common above 26"
X Link 2025-12-10T15:26Z 9426 followers, 2287 engagements

"$PATH UiPath Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $411.113M Beat $392.967M Estimate / UiPath Sees Q4 Sales $462.000M-$467.000M vs $462.909M Est"
X Link 2025-12-03T21:12Z 9426 followers, 7944 engagements

"$WRBY trimmed down to 1/3 size slightly above XX but wen 30"
X Link 2025-12-10T18:38Z 9426 followers, 2105 engagements

"$TEVA another lazy river T name along with $TERN"
X Link 2025-12-10T20:51Z 9426 followers, 1468 engagements

"$WAY Mizuho XX from XX Canaccord XX from XX Canaccord analyst Richard Close raised the firm's price target on Waystar to $XX from $XX and keeps a Buy rating on the shares. The firm said Waystar delivered another revenue and adj-EBITDA beat. The strong 3Q upside and expectation of continued core strength combined with the addition of the acquired Iodine's operation led to a solid 2025 guidance raise"
X Link 2025-10-30T12:13Z 9425 followers, 1584 engagements

"$EQX another gold name along with $B"
X Link 2025-11-26T18:54Z 9425 followers, XXX engagements

"$SNPS Synopsys Q4 Adj. EPS $XXXX Beats $XXXX Estimate Sales $2.255B Beat $2.247B Estimate / Synopsys Sees Q1 Adj EPS $3.52-$3.58 vs $XXXX Est; Sees Sales $2.365B-$2.415B vs $2.378B Est / Synopsys Sees FY2026 Adj EPS $14.32-$14.40 vs $XXXXX Est; Sees Sales $9.560B-$9.660B vs $7.044B Est"
X Link 2025-12-10T21:09Z 9425 followers, 2932 engagements

"$CAPR Oppenheimer raised the firm's price target on Capricor Therapeutics to $XX from $XX and keeps an Outperform rating on the shares. Today's announcement that binding terms for deramiocel's European commercialization have been agreed upon with partner Nippon Shinyaku gives Capricor access to another leading pharmaceutical market and signals third-party confidence in global regulatory prospects the analyst tells investors in a research note. The firm says the deal also extends the company's cash runway into 2026. Opco sees U.S. approval and launch by late 2025 and forecasts 2030 sales of"
X Link 2024-09-17T20:07Z 9414 followers, 4388 engagements

"$WAY 18M shs offering JPMorgan underwriter will add more if big pull"
X Link 2025-09-10T20:46Z 9414 followers, 3071 engagements

"$WAY nice bnce"
X Link 2025-09-17T15:03Z 9417 followers, 2967 engagements

"$DBRG 🙃 @Maximus_Holla @Sandman7591"
X Link 2025-10-14T15:57Z 9414 followers, 5436 engagements

"$DBRG quite some spread trades"
X Link 2025-10-14T18:57Z 9414 followers, 2967 engagements

"$DBRG OpenAI Oracle and Vantage Data Centers a leading global provider of hyperscale data center campuses today announced plans to develop a data center campus outside Milwaukee in Port Washington Wisconsin. The new campus is part of OpenAI and Oracles previously announced partnership to invest up to XXX gigawatts of additional Stargate capacity and is the Midwest site that was recently announced as part of OpenAIs Stargate expansion"
X Link 2025-10-22T20:06Z 9414 followers, 3911 engagements

"$VIAV intra high pcr .032"
X Link 2025-10-30T17:41Z 9416 followers, 1578 engagements

"$TVTX U.S. net product sales of FILSPARI (sparsentan) grew XXX% year-over-year to $XXXX million in 3Q 2025; XXX new PSFs received during the quarter Total revenue for 3Q 2025 was $XXXXX million including U.S. net product sales of $XXXXX million Retired remaining $XX million of 2025 convertible notes and achieved $XX million EU market access milestone further strengthening financial foundation 2025 KDIGO guidelines and streamlined REMS monitoring strengthen FILSPARIs position as a foundational nephroprotective therapy for IgAN Company well-positioned for potential FDA approval and commercial"
X Link 2025-10-30T20:24Z 9411 followers, 16.8K engagements

"$OS prob 200dma soon also had good ER"
X Link 2025-11-07T17:53Z 9417 followers, 3271 engagements

"$OS decent eod"
X Link 2025-11-10T20:49Z 9412 followers, 1724 engagements

"$ETOR near XX $X run so far"
X Link 2025-11-11T16:08Z 9416 followers, 2704 engagements

"$AMRX clean"
X Link 2025-11-11T19:42Z 9412 followers, 1192 engagements

"$AMRX Amneal Receives U.S. FDA Approval for Iohexol Injection"
X Link 2025-11-13T21:04Z 9412 followers, 1933 engagements

"Farallon: $ABVX $ALE $ALNY $AMZN $ASMB $BIDU $ONC $BCRX $CDTX $DOCS $LLY $GRAL $GH $ICLR $NTLA $IONS $K $MRUS $MLYS $MIRM etc"
X Link 2025-11-14T16:35Z 9414 followers, 2044 engagements

"$ETOR now Tiger Global stake per 13F"
X Link 2025-11-14T19:14Z 9416 followers, 1440 engagements

"$TVTX flaggy"
X Link 2025-11-24T17:54Z 9414 followers, 2473 engagements

"$AMTM Annual Revenues of $XXXX billion X% growth on a pro forma basis Annual Net Income of $XX million; Annual Adjusted EBITDA of $1104 million Annual Diluted Earnings Per Share of $0.27; Annual Adjusted Diluted Earnings Per Share of $XXXX Annual Operating Cash Flow of $XXX million; Annual Free Cash Flow of $XXX million Backlog of $XX billion; Book-to-Bill 1.6x Fourth Quarter 1.2x Full Year Reduced Net Debt to $XXX billion and Net Leverage to 3.2x"
X Link 2025-11-24T21:32Z 9416 followers, 2895 engagements

"$ANVS stopped out will revisit"
X Link 2025-12-01T17:52Z 9416 followers, 1990 engagements

"$PDD US Republican senator calls for DOJ and Homeland Security to investigate Shein Temu for counterfeiting"
X Link 2025-12-01T19:42Z 9412 followers, XXX engagements

"$RKT intra highs don't forget $UWMC"
X Link 2025-12-01T20:31Z 9416 followers, 1721 engagements

"$AMRX Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05%"
X Link 2025-12-01T21:01Z 9419 followers, 1182 engagements

"$GH Morgan Stanley analyst Tejas Savant assumed coverage of Guardant Health with an Overweight rating and a price target of $XXX up from $XXX. Life Science Tools and Diagnostics end market bright spots are beginning to emerge and the firm sees "plenty of catalysts" in the pipeline across its coverage adding that it sees "lots to like in the space entering 2026." However a recent industry valuation spike in the second half of the year leaves multiples in "a fair place" so the firm starts the group with an In-Line industry view the analyst tells investors. Among the group the analyst identifies"
X Link 2025-12-01T21:33Z 9414 followers, 2067 engagements

"$KURA Kura Oncology Inc. (Nasdaq: KURA Kura) a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer today announced the first U.S. commercial sale of KOMZIFTI (ziftomenib) has been completed. Under Kuras collaboration and license agreement with Kyowa Kirin Co. Ltd. and Kyowa Kirin Inc. (collectively Kyowa Kirin) this milestone triggers a $XXX million payment from Kyowa Kirin to Kura which Kura expects to receive prior to year-end. KOMZIFTI was approved by the U.S. Food and Drug Administration on November XX 2025"
X Link 2025-12-02T13:06Z 9418 followers, 1640 engagements

"$ADMA weekly prob XX break setup soon"
X Link 2025-12-02T15:58Z 9416 followers, 2403 engagements

"$MRVL upgrades Deutsche Bank XXX from XX Barclays XXX from XX Wells Fargo XXX from XX Piper Sandler XXX from XX Stifel XXX from XX Goldman Sachs XX from XX KeyBanc XXX from XX JPMorgan XXX from XXX Oppenheimer XXX from XXX Susquehanna XXX from 100"
X Link 2025-12-03T12:25Z 9415 followers, XXX engagements

"$AA nearing 44"
X Link 2025-12-03T15:29Z 9414 followers, XXX engagements

"$kss stopped out remaining"
X Link 2025-12-03T19:42Z 9419 followers, 1402 engagements

"$NUVB strong eod"
X Link 2025-12-03T20:55Z 9413 followers, 1370 engagements

"$TGT TARGET TESTS NEW MODELS FOR NEXT-DAY DELIVERY - WSJ"
X Link 2025-12-04T18:19Z 9418 followers, XXX engagements

"$SOFI SoFi Technologies Inc. (NASDAQ: SOFI) (SoFi or the Company) today announced an underwritten public offering of $XXX billion of shares of its common stock. In connection with the offering SoFi expects to grant the underwriter a 30-day option to purchase up to an additional XX% of the shares of common stock offered in the offering. All of the shares of common stock in the offering will be sold by SoFi. SoFi intends to use the net proceeds from the offering for general corporate purposes including but not limited to enhancing capital position increasing optionality and enabling further"
X Link 2025-12-04T21:18Z 9417 followers, 3232 engagements

"$DBRG buyout chatter Softbank halted up"
X Link 2025-12-05T15:14Z 9414 followers, 3345 engagements

"$VTYX starting to bnce some March spreaders"
X Link 2025-12-05T15:19Z 9414 followers, 2387 engagements

"$CNX Jan 38c large sweep"
X Link 2025-12-05T16:51Z 9415 followers, XXX engagements

"$VSCO JPMorgan analyst Matthew Boss upgraded Victoria's Secret to Overweight from Neutral with a price target of $XX up from $XX following the Q3 report. The stock in afternoon trading is up XX% or $XXXX to $XXXXX. A an earnings and sales "inflection" is underway at Victoria's the analyst tells investors in a research note. JPMorgan sees $XXXX in fiscal 2027 earnings per share power as a "base-case" based on "consistent" low- to mid-single-digit same-store-sales growth. It believes the company is seeing momentum into the holiday"
X Link 2025-12-05T18:56Z 9411 followers, 2564 engagements

"$IDYA On December X 2025 GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) (GSK) communicated to IDEAYA Biosciences Inc. (the Company) its election to terminate the Collaboration Option and License Agreement dated June XX 2020 (as amended the Agreement). Pursuant to the terms of the Agreement such termination will be effective ninety (90) days following the date of GSKs written notice. During the ninety-day transition period GSK will transfer the Werner Helicase (IDE275) and Pol Theta (IDE705) clinical programs to the Company in accordance with the applicable provisions of the Agreement. The"
X Link 2025-12-05T21:27Z 9414 followers, 1446 engagements

"$PATH weekly"
X Link 2025-12-08T14:35Z 9412 followers, 2385 engagements

"$ERAS Stifel analyst Laura Prendergast initiated coverage of Erasca (ERAS) with a Buy rating and $X price target. The firm highlights a valuation gap between Revolution Medicines' (RVMD) daraxonrasib and Erasca's ERAS-0015 telling investors that while the former's pan-RAS inhibitor is expected to have a substantial first-to-market advantage it believes the extensive total addressable market "leaves plenty of room for a major second mover." The firm models ERAS-0015 to launch in the second half of 2030 and generate $1.56B in revenue by 2035 the analyst tells investors"
X Link 2025-10-15T20:15Z 9420 followers, 1266 engagements

"$ADMA 3Q 2025 Total Revenue of $XXXXX Million a XX% YoY Increase 3Q 2025 GAAP Net Income of $XXXX Million a X% YoY Increase 3Q 2025 Adjusted EBITDA(1) of $XXXX Million a XX% YoY Increase 3Q 2025 Adjusted Net Income(2) of $XXXX Million an X% YoY Increase FDA Lot Release of First Yield-Enhanced Production Batches Positions ADMA for Margin Expansion Beginning in 4Q 2025 and Continuing Through 2026 Positive Statistically Significant Real-World Health Outcomes Demonstrated for ASCENIV Record ASCENIV Demand and Anticipated 2026 Payer Coverage Expansion Support Sustained and Accelerating Revenue"
X Link 2025-11-05T21:06Z 9418 followers, 6893 engagements

"$ADMA ADMA BIOLOGICS INC OUTLOOK 2026 TOTAL REVENUE: RAISED TO AT LEAST $XXX MILLION ADMA BIOLOGICS INC: FY 2029 TOTAL ANNUAL REVENUE GUIDANCE IS EXPECTED TO REACH $XXX BILLION OR MORE"
X Link 2025-11-05T22:28Z 9418 followers, 3414 engagements

"$RLMD hit 5"
X Link 2025-11-19T14:39Z 9417 followers, 2093 engagements

"$GH 10min after posting looks like there was a massive vol came in not sure if there was any news maybe $EXAS effect"
X Link 2025-11-19T20:50Z 9422 followers, 5059 engagements

"$ZIM ZIM Integrated Shipping Q3 EPS $XXXX Beats $XXXX Estimate Sales $1.777B Beat $1.766B Estimate"
X Link 2025-11-20T12:20Z 9420 followers, 1027 engagements

"$ADMA will prob exercise 15c"
X Link 2025-11-21T20:41Z 9419 followers, 2653 engagements

"$SLP Simulations Plus Q4 Adj. EPS $XXXX Beats $(0.05) Estimate Sales $17.500M Beat $17.095M Estimate / Simulations Plus Affirms FY2026 Adj EPS Guidance of $1.03-$1.10 vs $(3.22) Est; Affirms FY2026 Sales Guidance of $79.000M-$82.000M vs $78.797M Est"
X Link 2025-12-01T21:13Z 9420 followers, 2085 engagements

"$CRDO Credo Technology Group Q2 Adj. EPS $XXXX Beats $XXXX Estimate Sales $268.027M Beat $234.917M Estimate / Credo Technology Group Sees Q3 Sales $335.000M-$345.000M vs $247.043M Est"
X Link 2025-12-01T21:14Z 9420 followers, 3709 engagements

"$AEO AEO Total revenue increased X% to a record $XXX billion driven by total comparable sales increase of X% with positive results across brands Aerie comps +11% American Eagle comps +1% Momentum continues raises fourth quarter operating income guidance to $XXX to $XXX million on comp growth of X% to 9%"
X Link 2025-12-02T21:11Z 9421 followers, 4012 engagements

"$adma finally 20s"
X Link 2025-12-03T19:15Z 9419 followers, 1317 engagements

"$VSCO hitting 50s"
X Link 2025-12-08T19:40Z 9419 followers, 1223 engagements

"$TSM Jan 310c large sweep"
X Link 2025-12-08T20:20Z 9422 followers, XXX engagements

"$NVDA TRUMP: UNITED STATES WILL ALLOW NVIDIA TO SHIP ITS H200 PRODUCTS TO APPROVED CUSTOMERS IN CHINA AND OTHER COUNTRIES"
X Link 2025-12-08T21:31Z 9418 followers, 2614 engagements

"$NVDA $AMD $INTC TRUMP: SAME APPROACH WILL APPLY TO AMD INTEL AND OTHER GREAT AMERICAN COMPANIES"
X Link 2025-12-08T21:33Z 9418 followers, 1600 engagements

"$KYMR upgardes so far Jefferies XXX from XX Truist XXX from XX HCW XXX from XX Oppenheimer XXX from XX Morgan Stanley XXX from XX Piper Sandler XXX from XX Citi XXX from XX BofA XXX from XX Wells Fargo XXX from XX Barclays XXX from 70"
X Link 2025-12-09T19:36Z 9425 followers, XXX engagements

"$GEM 13.9ish big level"
X Link 2025-12-10T21:39Z 9426 followers, 1396 engagements

"$OLMA Goldman Sachs raised the firm's price target on Olema Oncology (OLMA) to $XX from $XX and keeps a Buy rating on the shares. Roche's (RHHBY) detailed Phase X lidERA results for giredestrant at the San Antonio Breast Cancer Symposium showed encouraging efficacy with a safety/tolerability profile that supports SERD monotherapy as a viable adjuvant option for ER+/HER2- breast cancer offering positive read-through for Olema's palazestrant and its potential to expand into the large adjuvant market the analyst tells investors in a research note"
X Link 2025-12-11T12:38Z 9425 followers, 2048 engagements

"$IOT back to 40s"
X Link 2025-10-06T18:02Z 9423 followers, 3387 engagements

"$SNPS $NVDA NVIDIA and Synopsys Announce Strategic Partnership to Revolutionize Engineering and Design"
X Link 2025-12-01T13:04Z 9425 followers, 4495 engagements

"$PATH Canaccord XX from XX Wells Fargo XX from XX Barclays XX from XX Mizuho XX from XX Evercore XX from XX Evercore ISI raised the firm's price target on UiPath to $XX from $XX and keeps an In Line rating on the shares after the company delivered what the firm describes as "solid" fiscal Q3 results that showcase early momentum in AI and agentic automation. The company surpassed expectations for ARR revenue and operating margins while management's constructive tone highlighted strong customer engagement and expanding deployments the analyst tells investors in a post-earnings note"
X Link 2025-12-04T13:19Z 9423 followers, 1537 engagements

"$MP Morgan Stanley upgraded MP Materials to Overweight from Equal Weight with a price target of $XX up from $XXXXX. The firm says China's one-year pause on rare earth restrictions does not solve the U.S.'s critical mineral dependency issues. MP is positioned to benefit as the U.S. looks to develop a robust supply chain outside of China the analyst tells investors in a research note. Morgan Stanley sees potential for more commercial deals to be announced as magnet users diversify"
X Link 2025-12-05T12:17Z 9423 followers, 3010 engagements

"$TERN XX holla"
X Link 2025-12-05T18:19Z 9426 followers, 3198 engagements

"$TERN upgrades HCW XX from XX Mizuho XX from XX Truist XX from XX BMO Capital XX from XX Barclays XX from 36"
X Link 2025-12-09T12:49Z 9425 followers, 3543 engagements

"$WRBY watching for continuation"
X Link 2025-12-09T14:41Z 9426 followers, 2160 engagements

"$RLMD holding well"
X Link 2025-12-09T14:50Z 9426 followers, XXX engagements

"$APGE Deutsche Bank initiated coverage of Apogee Therapeutics with a Buy rating and $XXX price target"
X Link 2025-12-09T23:12Z 9424 followers, 3509 engagements

"$IRDM ceo $346k worth at 17.33"
X Link 2025-11-03T21:32Z 9425 followers, 1887 engagements

"$PTCT PTC Therapeutics Q3 EPS $XXXX Beats $(1.42) Estimate Sales $211.007M Beat $185.251M Estimate / PTC Therapeutics Raises FY2025 Sales Guidance from $650.000M-$800.000M to $750.000M-$800.000M vs $1.733B Est"
X Link 2025-11-04T21:26Z 9425 followers, 1055 engagements

"$MLCO ww especially after regular session open Casino sector doing well has presence in Asia quite positive looking ER # across Macau Cyprus Philliphines region. Melco Resorts and Enter Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $1.309B Beat $1.282B Estimate"
X Link 2025-11-06T13:44Z 9425 followers, 4741 engagements

"$ETOR vs recent low area"
X Link 2025-11-10T15:37Z 9426 followers, 4993 engagements

"$SG not much total premium so far but pcr .345 SI 21.4%"
X Link 2025-11-13T20:07Z 9425 followers, 3452 engagements

"$SG locked a few"
X Link 2025-11-14T17:52Z 9426 followers, 3149 engagements

"Baker Bros: $ABVX $AGIO $ACLX $ARWR $RNA $ONC $CDTX $CRNX $CTMX $HRTX $DNTH $LBRX $MBX $NUVL $PHVX $RAPP $SYRE $VTYX $VKTX $VYNE etc"
X Link 2025-11-14T21:34Z 9426 followers, 15.6K engagements

"$ODD :ODDITY Tech Q3 Adj. EPS $XXXX Beats $XXXX Estimate Sales $147.900M Beat $145.436M Estimate / ODDITY Tech Raises FY2025 Adj EPS Guidance from $1.99-$2.04 to $2.10-$2.12 vs $XXXX Est; Raises FY2025 Sales Guidance from $790.000M-$798.000M to $806.000M-$809.000M vs $803.521M Est"
X Link 2025-11-19T21:25Z 9426 followers, XXX engagements

"$GAP prob good watch off ER Gap Q3 EPS $XXXX Beats $XXXX Estimate Sales $3.942B Beat $3.910B Estimate / Gap Raises FY2025 Sales Guidance from $15.251B-$15.402B to $15.357B-$15.402B vs $15.324B Est / *Gap Inc. Raises Full-Yr Outlook for Operating Margin"
X Link 2025-11-21T13:36Z 9425 followers, 3156 engagements

"$SG hit 6.6s today"
X Link 2025-11-21T18:16Z 9425 followers, 3236 engagements

"$VTGN wen 5"
X Link 2025-11-24T15:46Z 9425 followers, 2222 engagements

"$RKT r/g interesting March spreader"
X Link 2025-12-01T20:01Z 9425 followers, 3449 engagements

"$BMEA BMEA Biomea Fusion Reports Durable Glycemic And C-Peptide Improvements X Months After Last Dose In COVALENT-111 With Icovamenib"
X Link 2025-12-05T13:29Z 9425 followers, 3053 engagements

"$QCOM not bad trend"
X Link 2025-12-05T15:07Z 9425 followers, 2516 engagements

"$TVTX intra block today"
X Link 2025-12-08T20:24Z 9425 followers, 1344 engagements

"$TE Alliance Global analyst Jake Sekelsky initiated coverage of T1 Energy with a Buy rating and $XXXX price target. The firm believes T1 is positioned to become a leading vertically integrated solar manufacturer. The company will serve as a "key player" in securing the broader solar supply chain in the United States the analyst tells investors in a research note. Alliance says current share price levels "represent an attractive entry point ahead of a catalyst-rich 2026.""
X Link 2025-12-09T12:50Z 9425 followers, 3265 engagements

"$APLD 28c deep ITM + 500%"
X Link 2025-12-09T16:09Z 9425 followers, 1522 engagements

"$FULC decent come back"
X Link 2025-12-09T17:39Z 9425 followers, 2972 engagements

"$SG decent come back one of sqz candidates"
X Link 2025-12-09T18:06Z 9426 followers, 2184 engagements

"$GDS got starter size today chinese data center name considering situation Trump vs Xi re:$NVDA H200 chips may see future boost in server infrastructure in terms of power and space. will add more on pull risk 30-31 zone"
X Link 2025-12-09T18:25Z 9425 followers, XXX engagements

"$SVRA boring side way for now will probably raise stop to 6ish"
X Link 2025-12-09T18:50Z 9425 followers, 2251 engagements

"$CMPS per @Quantumup1 Oppenheimer $CMPS: We're moving CMPS to Outperform with a $15PT (prev. Not Rated) based on our conviction for COMP360 to lead the revolution of psychedelic medicine for neruopsychiatry. We anticipate COMP360 (psilocybin) to become the first-ever FDA-approved classical psychedelic therapy for treatment-resistant depression (TRD) patients where we see a $1.5B peak sales opportunity. CMPS recently outlined an accelerated regulatory pathway with FDA alignment enabling potential launch in 2027. Meanwhile we see shares as attractive ahead of important readouts from the ongoing"
X Link 2025-12-09T21:32Z 9426 followers, 3146 engagements

"$ONON daily"
X Link 2025-12-10T15:42Z 9425 followers, XXX engagements

"$RKLB mini sqz space theme strong $RDW $LUNR $ASTS $DXYZ etc"
X Link 2025-12-10T16:59Z 9425 followers, 2506 engagements

"$WRBY decent"
X Link 2025-12-10T18:22Z 9425 followers, 2396 engagements

"$AIP couple more trimmed today"
X Link 2025-12-10T20:30Z 9426 followers, 2482 engagements

"$PL Delivered Record Revenue in Q3 of $XX Million Up +33% YoY Increased RPOs +361% YoY to $XXX Million; Backlog +216% YoY to $XXX Million Generated $XXX Million of Year-to-Date Net Cash Provided by Operating Activities End of Period Cash Cash Equivalents and Short-Term Investments Increased XXX% YoY to $XXX Million Successfully Launched X High Resolution Pelican Satellites & XX SuperDove Satellites"
X Link 2025-12-10T21:07Z 9426 followers, 5374 engagements

"$GEMI Gemini Receives US License for Prediction Markets"
X Link 2025-12-10T21:35Z 9425 followers, 3756 engagements

"$AAOI Rosenblatt raised the firm's price target on Applied Optoelectronics to $XX from $XX and keeps a Buy rating on the shares. The company received its first volume order for 800G transceivers from a major hyper scale customer to support artificial intelligence data center growth the analyst tells investors in a research note. The firm believes the announcement suggests one of Applied's 800G transceivers likely 800G OSFP 2xFR4 has gained final product qualification with Amazon and will begin shipping for revenues. "This is unquestionably positive news" according to Rosenblatt. However the"
X Link 2025-12-11T12:14Z 9426 followers, 1752 engagements

"$U BTIG XX Piper Sandler XX from XX Piper Sandler upgraded Unity to Overweight from Neutral with a price target of $XX up from $XX. The firm says the mobile app advertising market "looks healthy" entering 2026. Unity's Vector ad business has grown XX% quarter-over-quarter in the past two quarters the analyst tells investors in a research note. Piper sees an opportunity for the company's Grow segment to accelerate as Unity Vector ads scales at double-digits and Other Grow revenue stabilizes"
X Link 2025-12-11T12:52Z 9425 followers, 1118 engagements

"$PL upgrades Deutsche Bank XX from XX Wedbush XX from XX Clear street XX from 14"
X Link 2025-12-11T12:54Z 9425 followers, 1248 engagements

"$PL intra high"
X Link 2025-12-11T16:51Z 9426 followers, 2162 engagements

"$WRBY BTIG analyst Janine Stichter raised the firm's price target on Warby Parker (WRBY) to $XX from $XX and keeps a Buy rating on the shares. Warby Parker shares have surged on renewed attention to its AI-powered glasses collaboration with Google (GOOGL) which could ultimately be transformative but is unlikely to meaningfully affect 2026 results the analyst tells investors in a research note. The sizable long-term revenue opportunity is driving near-term trading enthusiasm though scaling may be slower than peers and current fundamentals remain secondary to the story the firm says"
X Link 2025-12-11T18:19Z 9425 followers, XXX engagements

"$AIP Arteris Inc. (Nasdaq: AIP) a leading provider of system IP for accelerating semiconductor creation in the AI era today announced it has entered into a definitive agreement to acquire Cycuity Inc. a leading provider of semiconductor cybersecurity assurance. The addition of Cycuitys technology and expertise strengthens Arteris product portfolio enabling chip designers to understand and improve data movement security in chiplets and SoCs. This pending acquisition addresses a growing industry concern about the increasing volume of sophisticated cyberattacks targeting the vast amounts of"
X Link 2025-12-11T21:39Z 9426 followers, 1232 engagements